Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SELEXIPAG
- Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
- A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
- Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension
- A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study
- A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging
- A Study of Selexipag in Healthy Male Participant
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
- A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
- A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
- A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects
- A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
- Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension
- Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.
- Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects
- Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects
- A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects
- Comparison of Two Dose Strengths of Selexipag in Healthy Adults
- The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
- Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
- Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
- Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects
- Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
Clinical trials list
click for details